Joint ICGEB – ALS Society of Canada Symposium on Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder

VENUE: UNIVERSITY CAMPUS RIJEKA 

DATE: June 30 - July 03, 2022

CONTACT: This email address is being protected from spambots. You need JavaScript enabled to view it.

REGISTER NOW! Registration link

icgeb logo  Capture2 
free vector als society of canada 0 040260 als society of canada 0 Capture

SESSIONS

  • ALS/FTD genetics and mechanisms
  • Proteinopathy in ALS/FTD
  • Immunity in ALS/FTD
  • Clinical studies, biomarkers and emerging therapies in ALS/FTD
  • Related brain disorders

 

SATELLITE EVENTS:

  • NeuroArt Exhibition, University Campus Rijeka

 

PLENARY TALK

Michael J. Strong (President of the Canadian Institutes of Health Research & Distinguished University Professor at Western University, London Ontario, Canada):

SARS-COV-2,global aging and neurodegeneration: is this the perfect storm?”

 

SCIENTIFIC  COMMITTEE

Ivana Munitic and Miranda Mladinic Pejatovic (Department of Biotechnology, University of Rijeka, Croatia)

Emanuele Buratti (ICGEB Trieste, Italy)

Jasna Kriz and Jean-Pierre Julien (Laval University, Canada)

Ervina Bilic (Clinical Hospital Center Zagreb, Croatia)

Vladimira Vuletic (Clinical Hospital Center Rijeka, Croatia)

Srecko Gajovic and Dinko Mitrecic (University of Zagreb School of Medicine, Croatia)

Pavle Andjus (University of Belgrade, Serbia)

Jasenka Mrsic Pelcic (Faculty of Medicine Rijeka, Croatia)

 

ORGANIZING COMMITTEE

Jelena Ban, Katarina Bulic, Marin Dominovic, Nikolina Prtenjaca, Josip Peradinovic, Toni Franjkic, Marija Marosevic, Ante Maslac, Sara Morzan and Marta Kolaric (Department of Biotechnology, University of Rijeka, Croatia)

Andrea Markovinovic (King's College London, London, UK)

 

INVITED SPEAKERS

Pavle Andjus (Faculty of Biology, University of Belgrade, Serbia)

Stanley Appel (Neurological Institute, Weill Cornell Medical College, Houston, USA)

Caterina Bendotti (Mario Negri Institute for Pharmacological Research, Milano, Italy)

Ervina Bilic (Clinical Hospital Center Zagreb, Croatia)

Séverine Boillée (Brain and Spinal cord Institute, Paris, France)

Valentina Bonetto (Mario Negri Institute for Pharmacological Research, Milano, Italy)

Robert Bowser (Barrow Neurological Institute, Phoenix, USA)

Ilija Brizic (Faculty of Medicine, University of Rijeka, Croatia)

Emanuele Buratti (ICGEB, Trieste, Italy)

Jason Cannon (Purdue University, West Lafayette, USA)

Neil Cashman (University of British Columbia, Vancouver, Canada)

Heather Durham (McGill University, Montreal, Canada)

Pietro Fratta (National Hospital for Neurology and Neurosurgery, London, UK)

Srecko Gajovic (University of Zagreb School of Medicine, Croatia)

Angela Genge (Montreal Neurological Institute and Hospital, Montreal, Canada)

Metka Ravnik-Glavac (Faculty of Medicine, University of Ljubljana, Slovenia)

Jean-Pierre Julien (CERVO Brain Research Center, Laval University, Quebec, Canada)

Silva Katusic Hecimovic (Ruder Boskovic Institute, Zagreb, Croatia)

Jasna Kriz (CERVO Brain Research Center, Laval University, Quebec, Canada)

Clotilde Lagier-Tourenne (Harvard Medical School, Boston, USA)

Letizia Mazzini (Eastern Piedmont University, Maggiore della Carità Hospital, Novara, Italy)

Christopher Miller (King’s College London, UK)

Dragomir Milovanovic (German Center for Neurodegenerative Diseases, Berlin, Germany)

Dinko Mitrecic (University of Zagreb School of Medicine, Croatia)

Giovanni Nardo (Mario Negri Institute for Pharmacological Research, Milano, Italy)

Laura Pasetto (Mario Negri Institute for Pharmacological Research, Milano, Italy)

Boris Rogelj (Jozef Stefan Institute, Ljubljana, Slovenia)

Michal Schwartz (Weizmann Institute of Science, Rehovot, Israel)

Michael Strong (Canadian Institutes of Health Research, Canada)

Christine Vande Velde (CHUM, University of Montreal, Canada)

Vladimira Vuletic (Clinical Hospital Center Rijeka, Hrvatska)